Bank Of New York Mellon Corp Abiomed Inc Transaction History

Bank Of New York Mellon Corp

$538 Trillion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$242.49 - $301.46 $4.12 Million - $5.13 Million	-17,011 Reduced 2.63%	629,095 $155 Million
Q2 2022 Aug 15, 2022	BUY	$224.73 - $338.64 $2.11 Million - $3.18 Million	9,394 Added 1.48%	646,106 $160 Million
Q1 2022 May 11, 2022	SELL	$277.25 - $366.29 $4.46 Million - $5.89 Million	-16,080 Reduced 2.46%	636,712 $211 Million
Q4 2021 Feb 11, 2022	SELL	$300.63 - $371.35 $4.73 Million - $5.85 Million	-15,742 Reduced 2.35%	652,792 $234 Million
Q3 2021 Nov 12, 2021	SELL	$310.19 - $376.2 $6.54 Million - $7.93 Million	-21,073 Reduced 3.06%	668,534 $218 Million
Q2 2021 Aug 11, 2021	BUY	$262.71 - $351.17 $691,452 - $924,279	2,632 Added 0.38%	689,607 $215 Million
Q1 2021 May 13, 2021	BUY	$285.92 - $355.13 $9.46 Million - $11.8 Million	33,095 Added 5.06%	686,975 $219 Million
Q4 2020 Feb 09, 2021	BUY	$251.88 - $324.2 $2.59 Million - $3.34 Million	10,295 Added 1.6%	653,880 $212 Million
Q3 2020 Nov 12, 2020	BUY	$255.22 - $317.0 $5.96 Million - $7.4 Million	23,342 Added 3.76%	643,585 $178 Million
Q2 2020 Aug 12, 2020	BUY	$141.4 - $257.09 $5.2 Million - $9.46 Million	36,797 Added 6.31%	620,243 $150 Million
Q1 2020 May 06, 2020	SELL	$130.51 - $196.01 $3.45 Million - $5.19 Million	-26,466 Reduced 4.34%	583,446 $84.7 Million
Q4 2019 Feb 14, 2020	SELL	$159.31 - $223.54 $14.4 Million - $20.1 Million	-90,084 Reduced 12.87%	609,912 $104 Million
Q3 2019 Nov 07, 2019	BUY	$175.89 - $279.23 $5.33 Million - $8.46 Million	30,281 Added 4.52%	699,996 $125 Million
Q2 2019 Aug 12, 2019	BUY	$250.96 - $284.94 $30.1 Million - $34.1 Million	119,783 Added 21.78%	669,715 $174 Million
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $15.7 Million - $20.5 Million	56,709 Added 11.5%	549,932 $157 Million
Q4 2018 Feb 11, 2019	SELL	$281.08 - $444.25 $30.7 Million - $48.5 Million	-109,198 Reduced 18.13%	493,223 $160 Million
Q3 2018 Nov 09, 2018	SELL	$354.53 - $449.75 $12 Million - $15.2 Million	-33,869 Reduced 5.32%	602,421 $0
Q2 2018 Aug 06, 2018	SELL	$278.07 - $446.21 $57.8 Million - $92.8 Million	-207,968 Reduced 24.63%	636,290 $260 Million
Q1 2018 May 15, 2018	BUY	$192.49 - $295.85 $31.2 Million - $48 Million	162,251 Added 23.79%	844,258 $246 Million
Q4 2017 Feb 09, 2018	BUY	$168.78 - $199.74 $115 Million - $136 Million	682,007	682,007 $128 Million

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of New York Mellon Corp with notifications on news.

Account